Upstream Biosciences Inc. (OTC BB: UPBS) ("Upstream" or "the Company"), an emerging leader in the field of genetic diagnostics for cancer and the prediction of drug response, has announced today that it entered into a lease agreement with the BC Cancer Agency.
